Jagiellonian University Repository

The phase 3 study ECHELON-1 evaluating brentuximab vedotin in patients with newly diagnosed hodgkin lymphoma leaves important questions unanswered

pcg.skipToMenu

The phase 3 study ECHELON-1 evaluating brentuximab vedotin in patients with newly diagnosed hodgkin lymphoma leaves important questions unanswered

Bibliographic description

Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Na tych samych warunkach 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Na tych samych warunkach 4.0 Międzynarodowa